PD 98059 (DMSO solution), MEK1 inhibitor
Be the first to review this product! Submit a review
|
(4 Publications)
MW 267.28 Da, Purity >98%. Inhibitor of MKK1 (MEK1). Achieve your results faster with highly validated, pure and trusted compounds.
View Alternative Names
(R)-limonene 6-monooxygenase, (S)-limonene 6-monooxygenase, (S)-limonene 7-monooxygenase, 1,8-cineole 2-exo-monooxygenase, AI838772, AW493413, Albendazole monooxygenase, Albendazole sulfoxidase, Antigen NY-CO-13, BCC7, BCD541, C-mpl ligand, CP2C9_HUMAN, CP33, CP34, CP3A4_HUMAN, CPC12, CPC8, CPC9, CPCJ, CYP2C, CYP2C10, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIC9, CYPIIIA3, CYPIIIA4, Cellular tumor antigen p53, Component of gems 1, Craf 1 transforming gene, Cyclooxygenase 3, included, Cyclooxygenase-1, Cytochrome P-450MP, Cytochrome P450 2C9, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 MP-4, Cytochrome P450 MP-8, Cytochrome P450 NF-25, Cytochrome P450 PB-1, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450, family 2, subfamily C, polypeptide 9, Cytochrome P450-PCN1, Dual specificity mitogen-activated protein kinase kinase 1, EC 1.14.99.1, ERK activator kinase 1, ERK-1, ERK-2, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ERT 2, ERT1, ESRL 1, ESRR A, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen-related receptor alpha, Estrra, Extracellular signal related kinase 1, Extracellular signal-regulated kinase 1, Extracellular signal-regulated kinase 2, FLJ11090, FLJ92943, Gemin-1, Glucocorticoid inducible P450, HGNC6877, HLP, HS44KDAP, HUMKER1A, Insulin-stimulated MAP2 kinase, LFS1, MAP Kinase, MAP kinase 1, MAP kinase 2, MAP kinase 3, MAP kinase isoform p42, MAP kinase isoform p44, MAP kinase kinase 1, MAP kinase/Erk kinase 1, MAP2K1, MAPK, MAPK 1, MAPK/ERK kinase 1, MAPKK 1, MEK 1, MEKK 1, MGC104252, MGC112732, MGC126680, MGC149605, MGC20180, MGC88320, MGDF, MK01_HUMAN, MK03_HUMAN, MKCSF, MKK 1, MP2K1_HUMAN, MPL ligand, MPLLG, Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, Megakaryocyte stimulating factor, Microsomal monooxygenase, Microtubule-associated protein 2 kinase, Mitogen Activated Protein Kinase Kinase 1, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, Mitogen-activated protein kinase 3, Murine sarcoma 3611 oncogene 1, Mutant tumor protein 53, Myeloproliferative leukemia virus oncogene ligand, NF 25, NR3B1, Nifedipine oxidase, Nuclear receptor subfamily 3 group B member 1, OTTHUMP00000020135, OTTHUMP00000125198, OTTHUMP00000174538, OTTHUMP00000174541, OTTHUMP00000223567, OTTHUMP00000223568, OTTHUMP00000224066, OTTHUMP00000226924, Oncogene RAF1, P38, P41, P450 III steroid inducible, P450 MP, P450 PB 1, P450 PCN1, P450, family III, P450C2C, P450C3, P450IIC19, P450IIC9, P53_HUMAN, PCOX1, PGG/HS, PGH synthase 1, PGH1_HUMAN, PGHS-1, PHS 1, PRKM 2, PRKM 3, PRKM1, PRKMK 1, PTGHS, PTGS1, Partial COX1 proteins, included, Phosphoprotein p53, Prostaglandin G/H synthase 1, Prostaglandin H2 synthase 1, Prostaglandin-endoperoxide synthase 1, Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), Protein Kinase Mitogen Activated 3, Protein kinase mitogen activated kinase 1 (MAP kinase kinase 1), Quinine 3-monooxygenase, RP24-311F12.2, Raf proto oncogene serine threonine protein kinase, S-mephenytoin 4-hydroxylase, SCAN1, SMA, SMA 1, SMA 2, SMA 3, SMA 4, SMN1, SMN2, SMNT, SMN_HUMAN, Sarcoma 3611 oncogene, Steroid hormone receptor ERR1, Survival motor neuron protein, Survival of motor neuron 1, telomeric, T-BCD541, THCYT1, TRP53, TYDP, TYDP1_HUMAN, Taurochenodeoxycholate 6-alpha-hydroxylase, Thrombopoietin, Thrombopoietin nirs variant 1, Tp53, Transformation related protein 53, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, Xenobiotic monooxygenase, cytochrome P-450 S-mephenytoin 4-hydroxylase, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, hERR1, p42-MAPK, p44-ERK1, p44-MAPK, p53 tumor suppressor, protein kinase mitogen-activated kinase 1, protein kinase, mitogen-activated, 1, protein kinase, mitogen-activated, 2, protein tyrosine kinase ERK2, tumor antigen p55, vRaf1 murine leukemia viral oncogene homologue 1
- Chemical Structure
Lab
Chemical Structure - PD 98059 (DMSO solution), MEK1 inhibitor (AB146592)
2D chemical structure image of ab146592, PD 98059 (DMSO solution), MEK1 inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Handling instructions
Need more advice on solubility, usage and handling? Please visit our our product support page for more details.
|
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
|
Refer to SDS for further information.
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Cancers 14: PubMed36077661
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 13:928591 PubMed35992111
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic research : official publica 37:1387-1397 PubMed30644571
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cellular physiology and biochemistry : internation 50:2390-2405 PubMed30423583
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com